Metitepine

Metitepine

SCHEMBL14359602

CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2.CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 1.00
MAPT P10636 4/20 1.00
TP53 P04637 4/20 1.00
CYP3A4 P08684 4/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP2D6 P10635 3/20 1.00
HTR2C P28335 3/20 1.00
HTR1A P08908 2/20 1.00
HTR2A P28223 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
NPC1 O15118 2/20 1.00
MTOR P42345 2/20 1.00
RAB9A P51151 2/20 1.00
CYP2C19 P33261 2/20 1.00
ALDH1A1 P00352 1/20 1.00
HTT P42858 1/20 1.00
HTR5A P47898 1/20 1.00
HTR6 P50406 1/20 1.00
CYP2C9 P11712 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metitepine SCHEMBL7517783 1.00 HTR7 (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL113526 1.00 HTR7 (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL29496251 1.00 HTR7 (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL8169076 0.94 HTR7 (0.89) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL466985 0.92 MAPT (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL31360614 0.92 MAPT (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL15475310 0.91 MAPT (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
Metitepine SCHEMBL2048660 0.91 MAPT (1.00) HTR7MAPTTP53CYP3A4SMN1; SMN2
SCHEMBL8877190 0.88 MAPT (0.79) HTR7MAPTTP53CYP3A4SMN1; SMN2
SCHEMBL11876604 0.87 HTR7 (0.77) HTR7MAPTTP53CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726457-A1 INDOLEAMINE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES Adamed sp. z o.o. (PL) 2014-05-07 EP disclosed
WO-2013001499-A1 INDOLEAMINE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES ADAMED SP. Z O.O. (PL) 2013-01-03 WO disclosed